Thyrosafe 130 mg/1
Potassium iodide · TABLET · BTG International Inc
Thyrosafe is a tablet containing potassium iodide at 130 mg/1, taken oral. Manufactured by BTG International Inc.
Key Facts
- Brand Name
- Thyrosafe
- Generic Name
- Potassium iodide
- NDC Code (Product)
50633-920- Manufacturer
- BTG International Inc
- Strength
- 130 mg/1
- Dosage Form
- TABLET
- Route
- ORAL
- Marketing Status
- Application #
- ANDA076350
- Marketing Start
- 11/26/2025
Recall History
No Recall HistorySide Effects Reported to FDA
FDA FAERS database · These are reported events, not confirmed side effects
Full Prescribing Information
Indications & Usage
DIRECTIONS FOR USE Use only as directed by public officials if a nuclear radiation emergency happens.
Dosage & Administration
Dose: Adults over 18 years 1 tablet (whole or crushed) every day (130 mg) Children over 12 years to 18 years who weigh at least 150 pounds 1 tablet (whole or crushed) every day (130 mg) Children over 12 years to 18 years who weigh less than 150 pounds 1/2 tablet (whole or crushed) or 4 teaspoonfuls every day (65 mg) Children over 3 years to 12 years 1/2 tablet (whole or crushed) or 4 teaspoonfuls every day (65 mg) Children over 1 month 2 teaspoonfuls every day (32.5 mg) Babies at birth to 1 month 1 teaspoonful every day (16.25 mg) Tablets can be crushed and mixed in many liquids. To take the tablet in liquid solution, use dosing directions under Making a Potassium Iodide Liquid Mixture. Take KI every day (every 24 hours) as directed by public officials. Do not take more than 1 dose in 24 hours. More will not help you. Too much medicine may increase the chances of side effects. Making a Potassium Iodide Liquid Mixture: 1. Put one 130 mg KI tablet into a small bowl and grind it into a fine powder using the back of a metal teaspoon against the inside of the bowl. The powder should not have any large pieces. 2. Add 4 teaspoonfuls of water to the crushed KI powder in the bowl and mix un…
Warnings
WARNING People who are allergic to iodine, have dermatitis herpetiformis or hypocomplementemic vasculitis, or have nodular thyroid disease with heart disease should not take KI. Keep out of the reach of children. In case of an allergic reaction (difficulty breathing, speaking or swallowing; wheezing; shortness of breath or swelling of the mouth or throat), call 911 or get medical care right away. In case of overdose, get medical help or call a Poison Control Center right away.
Frequently Asked Questions
What is Thyrosafe used for?
Thyrosafe contains Potassium iodide. It is a tablet taken oral. Consult your doctor for specific uses.
Is Thyrosafe a controlled substance?
Thyrosafe is not classified as a controlled substance by the DEA.
What is the generic name for Thyrosafe?
The generic name for Thyrosafe is Potassium iodide. There are 11 other brand versions of Potassium iodide.
What is the NDC code for Thyrosafe 130 mg/1?
The NDC (National Drug Code) for Thyrosafe 130 mg/1 is 50633-920, listed by BTG International Inc.
Other Potassium Brands
See all →- POTASSIUM IODIDE1 g/mL75834-280
- SSKI1 g/mL17856-0114
- Kali iodatum5 [hp_C]/5[hp_C]0220-2798
- Kali iodatum1 [hp_M]/[hp_M]0220-2804
- Kali iodatum6 [hp_X]/10220-2887
- POTASSIUM IODIDE1 g/mL72162-2423
- IOSAT130 mg/151803-001
- Kali iodatum12 [hp_C]/12[hp_C]0220-2801
- Kali iodatum6 [hp_C]/6[hp_C]0220-2799
- Kali iodatum200 [kp_C]/200[kp_C]0220-2803
Not medical advice. Always consult your doctor or pharmacist before making any medication decisions.
Data from openFDA · Public domain (CC0 1.0)